Replies to post #323704 on Avid Bioservices Inc (CDMO)

[revenue_monster]

i agree. it was biopharms post that was replied to saying that info was not accurate. it should be the 19 who did not enroll!

biopharm wrote. “We still have not heard about the 19 patients of 22 for Yervoy + Bavituximab “

[biopharm]

You are incorrect

Bavi+Yervoy slide 8 of 10.....
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=110688499

[north40000]

Memory tells me that the 19 patients everyone is talking about are 19 that were in the treatment arm of the Sunrise trial who, on stop, walked away to be subsequently in one of the MRK or BMY Keytruda or Opdivo alone(or + Yervoy) trials for NSCLC, having been pre-treated with Bavi or Bavi + Docetaxel. Last I heard those patients were still alive, some having returned to work.

I am not going to look for it now, but again memory says the fact could have been on a slide from 2016 ASM, or else also reported to me(with no specific number known to him at the time) at AACR 2017 by Shan. JDM may remember discovering that info on the slide. A name search will help.

CJG's archives contain the info where I will look again later this evening.